Key facts
- Notable investors include Innoangel Fund, Tsinghua Capital, Lingyi Capital, Richland Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Zhiyuan Shenlan
- ·The full record, as it builds
Funding rounds
No funding rounds for Zhiyuan Shenlan are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Zhiyuan Shenlan
Provider of data-driven biomolecular design and manufacturing solutions designed for advancements in biotechnology. The company focuses on utilizing data-driven approaches to create innovative biomolecular designs, providing efficient and precise solutions for the biotech industry.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2024
- Ownership
- Privately Held (backing)
Zhiyuan Shenlan doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Zhiyuan Shenlan shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Zhiyuan Shenlan in its N-PORT filings yet. We sweep new filings monthly.